PMC Long Report: Analysis of the Opportunities, Challenges and Future of Personalized Medicine
The line is based on a recent report released today by the Personalized Medicine Coalition (PMC), which has seen a 62% increase in the number of marketed drugs developed based on personalized medical solutions. Even so, the PMC report still points to the enormous challenges facing personalized medicine while facing enormous challenges. While personalized medicine can ensure that patients get the right medication at the right dose, increase treatment effectiveness and reduce adverse events, personalized medicine also faces challenges such as reimbursement or clinical adoption and recognition. At the same time, the report also shows the future of personalized medicine. opportunity The pursuit of personalization in medicine has been more than two thousand years old. In ancient times, Hippocrates comprehensively evaluated four body fluids: blood, mucus, yellow bile, and black bile, hoping to treat each patient in the best way. Today we are better able to achieve personalized treatment through more advanced technologies such as sequencing. The data show that the same treatment is sometimes only effective for some patients, but not for the other, and a drug may only have side effects for some people, and this gap is particularly prominent in cancer treatment. The report lists the benefits of personalized medicine for patients: The focus of medical care has changed from treatment to prevention Guide targeted therapy and reduce inappropriate treatment Reduce the incidence of adverse drug reactions Reveal current treatments and other targeting of drugs Improve patient compliance with treatment Reduce high-risk invasive detection Reduce overall health care costs At the same time, the PMC lists some successful examples including the HER2 test. The authors of the report write that about 30% of breast cancer patients have HER2 gene overexpression, and personalized targeted drug therapy can reduce the risk of breast cancer recurrence in these patients by 52%. At the same time, personalized medicine can also help determine the possible adverse drug reactions in such patients. Regardless of whether you accept it or not, we have to say that “the era of personalized medicine has arrived†and the PMC report shows a steady increase in individualized drugs (see below). Bio Ethanol Fuel,Fuel Ethanol,Ethanol Fuel For Cars,Environment Good Ethanol Fuel JILIN COFCO BIO-CHEM AND BIO-ENERGY MARKETING CO., LTD , https://www.cofco-biotech.com
